Cell Therapeutics (CTIC) +32.4% premarket after receiving a positive opinion for conditional...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC+32.4% premarket after receiving a positive opinion for conditional approval of its pixuvri lymphoma treatment from the European Medicines Agency. CTIC expects that a marketing authorization should be granted by the European Commission within a few months.